← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $554K of Intra-Cellular Therapies, Inc.

Sold$554,491
$70.13Price
7,907Shares
−21%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Mon, Feb 26. Filed Tue, Feb 27, 2:58 PM ET, during the session. Not investment advice.